This document provides an overview of the numerous benefits of group housing during preclinical Drug Development, Safety Pharmacology and Toxicology studies.
The document also discusses how emka’s digital telemetry facilitates social housing and helps generate better data during wireless recordings of physiological signals.
By browsing this website, you accept the use of cookies for statistical purposes.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.
